Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Inventory: 2014-2016

Historic Inventory for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Dec 2016 value amounting to $64,000.

  • Viridian Therapeutics, Inc.\DE's Inventory fell 65.78% to $64,000 in Q4 2016 from the same period last year, while for Dec 2016 it was $64,000, marking a year-over-year decrease of 65.78%. This contributed to the annual value of $64,000 for FY2016, which is 65.78% down from last year.
  • Per Viridian Therapeutics, Inc.\DE's latest filing, its Inventory stood at $64,000 for FY2016, which was down 65.78% from $187,000 recorded in FY2015.
  • Viridian Therapeutics, Inc.\DE's Inventory's 5-year high stood at $187,000 during FY2015, with a 5-year trough of $64,000 in FY2016.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Inventory averaged around $143,333, with its median value being $179,000 (2014).
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Inventory rose by 4.47% in 2015, and later tumbled by 65.78% in 2016.
  • Viridian Therapeutics, Inc.\DE's Inventory (Yearly) stood at $179,000 in 2014, then rose by 4.47% to $187,000 in 2015, then slumped by 65.78% to $64,000 in 2016.